Skip to main content

Table 3 Variation of FEV1 during follow up

From: A pilot trial on safety and efficacy of erythrocyte-mediated steroid treatment in CF patients

 

Erythrocyte mediated steroid therapy

Ordinary therapy

P value

FEV1 at enrolment (-12 months), average (95% CI)

53.8 (25.6–82.0)

56.8 (30.0–83.6)

0.68

FEV1 at time +12, average (95% CI)

56.7 (23.8–89.6)

55.1 (26.5–83.7)

0.83

FEV1 at time +24, average (95% CI)

59.8 (22.4–97.2)

53.2 (21.7–84.7)

0.48